Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
Non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), who had malignant disease. However, their use in cancer patients increases and real-life evidence for their effectiveness...
Saved in:
| Main Authors: | Anetta Undas, Leszek Drabik |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KARE Publishing
2019-12-01
|
| Series: | Anatolian Journal of Cardiology |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-30766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)
by: E. I. Baranova, et al.
Published: (2020-02-01) -
Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with liver disease: a systematic review and meta-analysis
by: Qiang Zhou, et al.
Published: (2025-07-01) -
Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation
by: M. A. Gabitova, et al.
Published: (2020-01-01) -
Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01) -
Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)